Stephen Berenson Seres Therapeutics, Inc. (MCRB) insider trading activity

Stephen Berenson is of Seres Therapeutics, Inc.. Currently has a direct ownership of 3,589 shares of MCRB, which is worth approximately $2,942. The most recent transaction as insider was on Nov 23, 2020, when has been sold 3,589 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.59K

0% 3M change

0% 12M change

Total Value Held $2,942

Stephen Berenson Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Nov 23 2020	BUY Other acquisition or disposition	-	3,589 Added 50.0%	3,589 Common Stock

Also insider at

MRNA

Moderna, Inc. Healthcare

Director